Dynamic Hepatic Scintigraphy in Colorectal Cancer
Author Information
Author(s): D.M. Hemingway, T.G. Cooke, G. McCurrach, R.G. Bessent, R. Carter, J.H. McKillop, C.S. McArdle
Primary Institution: The Royal Infirmary, Glasgow
Hypothesis
Can dynamic hepatic scintigraphy accurately identify liver metastases in patients with colorectal cancer?
Conclusion
Dynamic hepatic scintigraphy is effective in identifying liver metastases in colorectal cancer patients.
Supporting Evidence
- The diagnostic sensitivity of the HPI was 96% in patients with liver metastases.
- The negative predictive value for dynamic scintigraphy was 93%.
- An elevated HPI was found in 23 of 24 patients with confirmed liver metastases.
Takeaway
Doctors used a special scan to see if patients with colon cancer had liver tumors, and it worked really well.
Methodology
Fifty patients underwent dynamic hepatic scintigraphy with a high administered activity of radiolabelled colloid.
Potential Biases
Some previous studies have shown conflicting results regarding the effectiveness of the technique.
Limitations
One study was unprocessable due to image overlap, and the study did not include patients without cancer.
Participant Demographics
Patients with colorectal cancer, including those with and without liver metastases.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website